These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8523204)
1. Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins. Mahieu LM; Holm SE; Goossens HJ; Van Acker KJ J Pediatr; 1995 Dec; 127(6):987-9. PubMed ID: 8523204 [TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections. Musser JM Pediatr Ann; 1992 Dec; 21(12):821-2, 825-8. PubMed ID: 1480436 [No Abstract] [Full Text] [Related]
3. [The return of severe infections caused by Streptococcus pyogenes]. Verhoef-Verhage EA; van Houten A; Joore JC; Verbrugh HA Ned Tijdschr Geneeskd; 1993 Mar; 137(12):604-7. PubMed ID: 8459859 [TBL] [Abstract][Full Text] [Related]
4. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients. Norrby-Teglund A; Low DE; McGeer A; Kotb M Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714 [No Abstract] [Full Text] [Related]
5. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult. Vucicevic Z; Bencic IJ; Kruslin B; Degoricija V J Microbiol Immunol Infect; 2008 Aug; 41(4):351-4. PubMed ID: 18787744 [TBL] [Abstract][Full Text] [Related]
6. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. Stevens DL; Tanner MH; Winship J; Swarts R; Ries KM; Schlievert PM; Kaplan E N Engl J Med; 1989 Jul; 321(1):1-7. PubMed ID: 2659990 [TBL] [Abstract][Full Text] [Related]
7. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. Mascini EM; Jansze M; Schellekens JF; Musser JM; Faber JA; Verhoef-Verhage LA; Schouls L; van Leeuwen WJ; Verhoef J; van Dijk H J Infect Dis; 2000 Feb; 181(2):631-8. PubMed ID: 10669348 [TBL] [Abstract][Full Text] [Related]
8. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies. Mascini EM; Hazenberg MM; van Dalen A; Verhoef-Verhage LA; van Leeuwen NJ; Verhoef J; van Dijk H Adv Exp Med Biol; 1997; 418():921-2. PubMed ID: 9331799 [No Abstract] [Full Text] [Related]
9. Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B. Mascini EM; Jansze M; Verhoef J; van Dijk H Clin Diagn Lab Immunol; 1999 Nov; 6(6):977-80. PubMed ID: 10548596 [TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome. Forni AL; Kaplan EL; Schlievert PM; Roberts RB Clin Infect Dis; 1995 Aug; 21(2):333-40. PubMed ID: 8562741 [TBL] [Abstract][Full Text] [Related]
12. Streptococcal pyrogenic exotoxin G gene in blood and pharyngeal isolates of Streptococcus dysgalactiae subspecies equisimilis has a limited role in pathogenesis. Korem M; Hidalgo-Grass C; Michael-Gayego A; Nir-Paz R; Salameh S; Moses AE J Microbiol Immunol Infect; 2014 Aug; 47(4):292-6. PubMed ID: 23380619 [TBL] [Abstract][Full Text] [Related]
13. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. Eriksson BK; Andersson J; Holm SE; Norgren M J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857 [TBL] [Abstract][Full Text] [Related]
14. Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections. Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Reichardt W; Alouf JE Adv Exp Med Biol; 1997; 418():241-3. PubMed ID: 9331642 [No Abstract] [Full Text] [Related]
15. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults. Vucicevic Z; Jajic-Bencic I; Kruslin B; Degoricija V J Microbiol Immunol Infect; 2009 Jun; 42(3):276-9. PubMed ID: 19812863 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice. Pandey M; Calcutt A; Ozberk V; Chen Z; Croxen M; Powell J; Langshaw E; Mills JL; Jen FE; McCluskey J; Robson J; Tyrrell GJ; Good MF Sci Adv; 2019 Sep; 5(9):eaax3013. PubMed ID: 31517054 [TBL] [Abstract][Full Text] [Related]